Mounjaro
Mounjaro is a weekly injectable medication for type 2 diabetes that improves blood sugar control by activating GIP and GLP-1 receptors.
- The description claims that Mounjaro helps lower A1C levels and often leads to significant weight loss.
- The description claims that Mounjaro is not approved for weight loss or for use in people with type 1 diabetes.
Variants (1)
- Default Title — 835.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
62%